胰岛素治疗患者的脂肪肥大

Pub Date : 2017-09-01 DOI:10.12816/0047629

J. Nasser, F. Hammad, A. Omran

{"title":"胰岛素治疗患者的脂肪肥大","authors":"J. Nasser, F. Hammad, A. Omran","doi":"10.12816/0047629","DOIUrl":null,"url":null,"abstract":"146 Diabetes mellitus (DM) is becoming a global epidemic. Type 2 DM is the most common type of diabetes. Several studies found that, with time, most patients would eventually need insulin therapy as a treatment to control their blood sugar1,2. Early intervention is essential to control hyperglycemia and prevent or delay microvascular or macrovascular complications; insulin stands in the forefront in diabetes management3-5.","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Lipohypertrophy among Insulin - Treated Patients\",\"authors\":\"J. Nasser, F. Hammad, A. Omran\",\"doi\":\"10.12816/0047629\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"146 Diabetes mellitus (DM) is becoming a global epidemic. Type 2 DM is the most common type of diabetes. Several studies found that, with time, most patients would eventually need insulin therapy as a treatment to control their blood sugar1,2. Early intervention is essential to control hyperglycemia and prevent or delay microvascular or macrovascular complications; insulin stands in the forefront in diabetes management3-5.\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2017-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12816/0047629\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12816/0047629","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 3

摘要

146糖尿病正在成为一种全球性流行病。2型糖尿病是最常见的糖尿病类型。几项研究发现，随着时间的推移，大多数患者最终需要胰岛素治疗来控制血糖1，2。早期干预对于控制高血糖和预防或延迟微血管或大血管并发症至关重要；胰岛素在糖尿病管理中处于领先地位3-5。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

Lipohypertrophy among Insulin - Treated Patients

146 Diabetes mellitus (DM) is becoming a global epidemic. Type 2 DM is the most common type of diabetes. Several studies found that, with time, most patients would eventually need insulin therapy as a treatment to control their blood sugar1,2. Early intervention is essential to control hyperglycemia and prevent or delay microvascular or macrovascular complications; insulin stands in the forefront in diabetes management3-5.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助